ABOUT US

Endpoint Health

is a Precision-FirstTM
therapeutics company

We’re building a new kind of biopharma.

By rewriting the molecule-first drug development model, we aim to deliver precision therapies that have the potential to improve outcomes for patients with immune-mediated diseases.

Our vision is a world in which all patients get the best treatment possible for their unique biology and disease.

Selected Investors

Our Leadership Team

team-member
Jason Springs
Co-Founder, CEO
team-member
Diego Rey, PhD
Co-Founder, CSO
team-member
Leonardo Teixeira, PhD
Co-Founder, COO
team-member
David Leonard
Chief Administrative Officer
team-member
Penny Toren
SVP, Regulatory Affairs
team-member
Julie Friedman
VP, Therapeutics Operations and Program Management
team-member
Pamela Ha
VP, Finance
team-member
Norris Abella
Head of Development
team-member
Tim Foley
VP, Head of Therapeutic Business Development
team-member
Mona Khalid
VP, Value Demonstration, Health Economics & Patient Access

Our Advisors

team-member
Paul Brown, PhD
Strategic Advisor
team-member
Javier San Martin, MD
Strategic Advisor
team-member
Mike Varney, MD
Strategic Advisor
team-member
Chad Robins
Strategic Advisor